MDPI and ACS Style
Bamias, A.; Tzannis, K.; Zakopoulou, R.; Sakellakis, M.; Dimitriadis, J.; Papatheodoridi, A.; Rallidis, L.; Halvatsiotis, P.; Tsiara, A.; Kaparelou, M.;
et al. Risk for Arterial Thromboembolic Events (ATEs) in Patients with Advanced Urinary Tract Cancer (aUTC) Treated with First-Line Chemotherapy: Single-Center, Observational Study. Curr. Oncol. 2022, 29, 6077-6090.
https://doi.org/10.3390/curroncol29090478
AMA Style
Bamias A, Tzannis K, Zakopoulou R, Sakellakis M, Dimitriadis J, Papatheodoridi A, Rallidis L, Halvatsiotis P, Tsiara A, Kaparelou M,
et al. Risk for Arterial Thromboembolic Events (ATEs) in Patients with Advanced Urinary Tract Cancer (aUTC) Treated with First-Line Chemotherapy: Single-Center, Observational Study. Current Oncology. 2022; 29(9):6077-6090.
https://doi.org/10.3390/curroncol29090478
Chicago/Turabian Style
Bamias, Aristotelis, Kimon Tzannis, Roubini Zakopoulou, Minas Sakellakis, John Dimitriadis, Alkistis Papatheodoridi, Loukianos Rallidis, Panagiotis Halvatsiotis, Anna Tsiara, Maria Kaparelou,
and et al. 2022. "Risk for Arterial Thromboembolic Events (ATEs) in Patients with Advanced Urinary Tract Cancer (aUTC) Treated with First-Line Chemotherapy: Single-Center, Observational Study" Current Oncology 29, no. 9: 6077-6090.
https://doi.org/10.3390/curroncol29090478